Admission Date:  [**2116-10-28**]       Discharge Date:  [**2117-1-11**]  Date of Birth:   [**2116-10-28**]       Sex:  M  Service:Neonatology HISTORY OF PRESENT ILLNESS:  Baby [**Name (NI) **] [**Known lastname **] [**Known lastname **]-[**Known lastname 10940**] delivered at 28 and 6/7 weeks gestation weighing 880 g and was admitted to the Newborn Intensive Care Unit from Labor and Delivery for management of prematurity and respiratory distress.
He received bag mask ventilation with a quick increase in heart rate.
HOSPITAL COURSE:  Respiratory:  The infant received three doses of Survanta for respiratory distress syndrome and was placed on conventional ventilation on admission with maximum support.
Respiratory support was weaned after Survanta and then escalated again on day of life #2 requiring high-frequency ventilation with a mean airway pressure of 11 and an amplitude of 18.
The infant remained on high frequency oscillatory ventilation for 24 hours and was then placed back on conventional ventilation on day of life #4.
The infant was weaned to continuous positive airway pressure on day of life #5.
He required reintubation with assisted ventilation on day of life #17 secondary to increased apnea and abdominal distention.
The infant was weaned to nasal cannula oxygen on day of life #36 and then weaned to room air on day of life #42.
The infant was treated with caffeine citrate for apnea of prematurity.
The caffeine citrate was discontinued on day of life #47 ([**2116-12-14**]).
Cardiovascular:  The infant received a course of Indocin on day of life #2 for clinical evidence of a patent ductus arteriosis.
He never required support for blood pressure and has been hemodynamically stable throughout the hospitalization.
Enteral feeds were started on day of life #6 and advanced to full volume feeds on day of life #13.
Tube feedings were held on day of life #17 secondary to increased apnea and abdominal distention.
Calories were weaned prior to discharge to 24 cal/oz at discharge taking expressed breast milk with Enfamil powder added to equal 24 cal/oz.
Discharge weight is 2885 grams  GI:  The infant was treated with phototherapy for indirect hyperbilirubinemia.
The infant received one packed red blood cell transfusion during the hospital stay.
Infectious disease:  The infant received 72 hours of Ampicillin and Gentamicin following delivery for rule out sepsis.
The infant received Vancomycin and Gentamicin for rule out sepsis x 2 courses on day of life #[**9-11**] and day of life #17-19.
Feeds:  Breast milk enhanced with Enfamil with powder to equal 24 cal/oz.
IMMUNIZATIONS RECEIVED:  Received hepatitis B immunization on [**12-24**], DTAP on [**12-25**], HIB on [**12-25**], IPV on [**12-28**], PCV7 on [**12-28**], and Synagis on [**1-4**].
IMMUNIZATION RECOMMENDATION:  Synagis RSV prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria:  1) born at less than 32 weeks, 2) born between 32 and 35 weeks with plans for daycare during RSV season, with a smoker in the household or with preschool siblings, or 3) with chronic lung disease.
